Zai Lab
Jenny Tu has an extensive work history in the pharmaceutical industry. Jenny is currently employed at Zaiyao Medical as a Clinical Project Director, a role they have held since April 2022. Prior to their current position, Jenny worked as an Associate Clinical Project Director at the same company from October 2020 to March 2022. Before joining Zaiyao Medical, Jenny worked at Astellas from 2014 to 2019, where they held various roles such as Site Monitoring and Management Lead, Local Study Leader, and Lead CRA. From 2012 to 2014, they worked as a CRA at Allergan, and from 2011 to 2012 they worked as a CRA at AbbVie. Overall, Jenny has gained significant experience in clinical project management and monitoring throughout their career.
Jenny Tu attended Harbin Medical University from 2003 to 2010, where they obtained a Bachelor's degree in Pharmacy. Jenny also holds a certification as a pharmacist.
This person is not in any offices
Zai Lab
5 followers
Zai Lab Ltd is a biopharmaceutical company. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include three drug candidates with greater China rights and three drug candidates with global rights. The greater China rights drug candidates include Niraparib (ZL-2306), Omadacycline (ZL-2401) and ZL-2301. The global rights drug candidates include Fugan (ZL-3101), ZL-2302 and ZL-1101.